期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
冠状动脉支架置入后血管再狭窄与P2RY2基因单核苷酸多态性的相关性
1
作者 王朝霞 木尼热·吾不力 +3 位作者 马依彤 中山智祥 佐藤直之 菅间薰 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2009年第13期2480-2484,共5页
背景:越来越多的基础研究显示P2RY2基因在心血管系统中起重要的调节作用。已有研究表明,人类P2RY2基因可能与冠状动脉支架置入后再狭窄的发生相关。目的:验证人类P2RY2基因单核苷酸多态性与冠状动脉支架置入后再狭窄的相关性。设计、时... 背景:越来越多的基础研究显示P2RY2基因在心血管系统中起重要的调节作用。已有研究表明,人类P2RY2基因可能与冠状动脉支架置入后再狭窄的发生相关。目的:验证人类P2RY2基因单核苷酸多态性与冠状动脉支架置入后再狭窄的相关性。设计、时间及地点:病例-对照观察,于2006-03/2008-06在新疆医科大学第一附属医院心脏中心完成。对象:纳入冠状动脉支架置入后再狭窄患者32例,另外选择120例既往无心血管系统疾病史的人作为对照组。方法:选择P2RY2基因的5个单核苷酸多态性rs4944831,rs1783596,rs4944832,rs4382936及rs10898909,通过TaqMan单核苷酸多态性基因分型的方法进行基因分型。主要观察指标:分析并比较2组5个单核苷酸多态性基因型频率和等位基因频率的分布,并应用Logistic回归分析方法分析支架置入后再狭窄主要危险因素对结果的影响。结果:支架置入后再狭窄组与正常对照组相比,rs4944831在基因型和显性模型(TG+GG)的分布差异有显著性意义(P=0.039,0.040);rs10898909在隐性模型(AA)和等位基因的分布差异有显著性意义(P=0.022,0.039)。Logistic回归分析显示,TG+GG在2组的差异消失,而AA在2组的差异依然存在(P=0.016)。结论:人类P2RY2基因的rs10898909可作为冠状动脉支架置入后再狭窄的标志,其AA基因型与冠状动脉支架置入后再狭窄的发生有关。 展开更多
关键词 冠状动脉支架 置入后再狭窄 p2ry2 单核苷酸多态性
暂未订购
Association of G-protein coupled purinergic receptor P2Y2 with ischemic stroke in a Han Chinese population of North China 被引量:3
2
作者 Li-Ying Yuan Zhi-Yi He +1 位作者 Lei Li Yan-Zhe Wang 《Neural Regeneration Research》 SCIE CAS CSCD 2019年第3期506-512,共7页
The G-protein-coupled purinergic receptor P2Y2(P2RY2) plays an important role in the mechanism of atherosclerosis, which is relevant to ischemic stroke. This retrospective case-control study aimed to assess the relati... The G-protein-coupled purinergic receptor P2Y2(P2RY2) plays an important role in the mechanism of atherosclerosis, which is relevant to ischemic stroke. This retrospective case-control study aimed to assess the relationship between P2RY2 gene polymorphisms and ischemic stroke risk in the northern Han Chinese population. In this study, clinical data and peripheral blood specimens were collected from 378 ischemic stroke patients and 344 controls. The ischemic stroke participants were recruited from the First Affiliated Hospital of China Medical University and the First Affiliated Hospital of Liaoning Medical University. The controls were recruited from the Health Check Center at the First Affiliated Hospital of China Medical University. Ischemic stroke patients were divided into two subgroups according to the Trial of ORG 10172 in Acute Stroke Treatment(TOAST) classification: large-artery atherosclerosis(n = 178) and small-artery occlusion(n = 200) strokes. All subjects were genotyped for three single nucleotide polymorphisms(rs4944831, rs1783596, and rs4944832) in the P2RY2 gene using peripheral venous blood samples. The distribution of the dominant rs4944832 phenotype(GG vs. GA+AA) differed significantly between small-artery occlusion patients and control subjects(odds ratio(OR) = 1.720, 95% confidence interval(CI): 1.203–2.458, P < 0.01). Multivariable logistic regression analysis revealed that the GG genotype of rs4944832 was significantly more prevalent in small-artery occlusion patients than in control subjects(OR = 1.807, 95% CI: 1.215–2.687, P < 0.01). The overall distribution of the haplotype established by rs4944831-rs1783596-rs4944832 was significantly different between ischemic stroke patients and controls(P < 0.01). In ischemic stroke patients, the frequency of the G-C-G haplotype was significantly higher than in control subjects(P = 0.028), whereas the frequency of the T-C-A haplotype was lower than in control subjects(P = 0.047). These results indicate that the G-C-G haplotype of P2RY2 is a susceptibility haplotype for ischemic stroke. In addition, the GG genotype of rs4944832 may be associated with the development of small-artery occlusion in the northern Han Chinese population. The study protocol was approved by the Ethics Committee of the First Affiliated Hospital of China Medical University on February 20, 2012(No. 2012-38-1) and the First Affiliated Hospital of Liaoning Medical University, China, on March 1, 2013(No. 2013-03-1). All participants gave their informed consent. This trial was registered with the ISRCTN Registry(ISRCTN11439124) on October 24, 2018. Protocol version(1.0). 展开更多
关键词 nerve REGENERATION p2ry2 GENE ischemic stroke single nucleotide polymorphism CASE-CONTROL study haplotype northern Han Chinese POPULATION large-artery atherosclerosis small-artery occlusion hypertension candidate GENE neural REGENERATION
暂未订购
P2RY8-CRLF2重排的急性淋巴细胞白血病儿童的临床特征及预后分析 被引量:2
3
作者 郑湧智 乐少华 +12 位作者 郑浩 华雪玲 陈再生 郑灵 陈彩 李梅 蔡春霞 杨景辉 陈以乔 高琴丽 陈莹莹 李健 胡建达 《中国实验血液学杂志》 CAS CSCD 北大核心 2021年第2期311-315,共5页
目的:探讨P2RY8-CRLF2重排急性淋巴细胞白血病(ALL)儿童的临床特征及预后。方法:2016年1-12(B-ALL)患儿,根据有无P2RY8-CRLF2重排分为P2RY8-CRLF2重排组和P2RY8-CRLF2阴性组。P2RY8-CRLF2重排组患儿均接受CCLG-ALL 2008高危组(HR)方案治... 目的:探讨P2RY8-CRLF2重排急性淋巴细胞白血病(ALL)儿童的临床特征及预后。方法:2016年1-12(B-ALL)患儿,根据有无P2RY8-CRLF2重排分为P2RY8-CRLF2重排组和P2RY8-CRLF2阴性组。P2RY8-CRLF2重排组患儿均接受CCLG-ALL 2008高危组(HR)方案治疗,P2RY8-CRLF2阴性组患儿则按临床危险度分型接受不同强度化疗。结果:共检出P2RY8-CRLF2重排B-ALL患儿5例(4.6%),男4例,女1例,初诊中位年龄4(2-6)岁,初诊白细胞计数中位数26.12(2.46-525.1)×109/L,3例为普通B细胞型,2例早期前B细胞型;1例46,XY,der(20)[22]/46,XY[2],4例为正常核型。P2RY8-CRLF2重排组中,诱导缓解治疗第33天有1例(20%)未达完全缓解,2例(40%)微小残留病≥1%;P2RY8-CRLF2阴性组中,诱导缓解治疗第33天均达完全缓解率,6例(5.8%)微小残留病≥1%。P2RY8-CRLF2重排组3年无事件生存率显著低于P2RY8-CRLF2阴性组(60.0%±21.9%vs 85.9%±3.9%)(P=0.049)。结论:伴有P2RY8-CRLF2融合基因阳性的ALL儿童早期治疗反应较差,预后不良,仍需要探索更有效的治疗方法。 展开更多
关键词 P2RY8-CRLF2重排 急性淋巴细胞白血病 儿童 预后
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部